Life Science & Therapeutics Intelligence

Stop Pitching to Small Clinics.
Get Verified BioTech ICPs.

The "Biology" category is flooded with 1-unit labs and student projects. Our AI agents verify clinical trial phases (IND/Phase I-III), bioreactor capacity, and patent depth to find verified Therapeutic Startups, Gene Therapy Labs, and CDMOs.

The "Lab" Data Mess

Why firmographic filters miss the high-CAPEX buyers.

Targeting "Life Sciences" tells you nothing about a company's ability to buy high-ticket instrumentation. You need to know what they synthesize and how they scale.

If you are selling bioreactors, HPLC systems, or clinical data APIs, you need the builders:

  • Clinical Diagnostics (Standard testing only)
  • University Department Pages (No budget)
  • Inactive Drug "Stealth" Shells
Metric Standard "Science" List Our ICP Database
Classification Broad (NAICS 5417) Therapeutic vs. Platform vs. CDMO
Tech Signals None Bioreactor & LIMS Verification
Buying Center Lab Manager CTO / Head of Clinical Ops
Clinical Unknown IND / Phase I-III Status Match

20 High-Value BioTech ICPs

Target builders of the future of human health.

Early-Stage Therapeutic Startups

Pre-clinical/Phase I firms. Targets for lab-sharing services, R&D chemicals, and specialized legal.

Gene & Cell Therapy Labs

CRISPR and viral vector innovators. Targets for genome data APIs, cleanroom gear, and sub-micron testing.

Bio-CDMOs (Contract Mfg)

Manufacturing for others. Targets for bioreactors, process control, and FDA validation data.

AI Drug Discovery Platforms

Generative AI for molecule design. Targets for GPU clusters, vector databases, and chemical datasets.

Orphan Drug Developers

Focus on rare diseases. Targets for specialized clinical trial networks and patient data APIs.

Microbiome Research Labs

Focus on gut/skin health. Targets for sequencing services, anaerobe chambers, and bio-data tools.

Bio-Defense & Vaccine Labs

Infectious disease focus. Targets for secure cloud, government grants, and high-security staffing.

Bio-Informatics SaaS

Software for sequence analysis. B2B targets for API data and cloud orchestration.

Custom Synthesis Shops

Building peptides/oligonucleotides. Targets for HPLC hardware, solvents, and B2B portals.

Life Science Investment (VC)

Investing in BioTech assets. Targets for due diligence and deal-flow data.

University Tech Transfer Labs

Translating campus research. Targets for IP management and student data.

Delivery System Startups

Transdermal and implantable tech. Targets for mechanical engineering and FDA legal.

Synthetic Biology Startups

Ginkgo/Zymergen clones. Targets for DNA synthesis partners and automation robotics.

Regulatory & CRO Boutiques

Handling FDA filings. Targets for document management and data research.

Bio-Logistics (Cold Chain)

Moving live tissue/cells. Targets for IoT sensors and specialized containers.

High-Resolution Imaging Labs

Cryo-EM and super-res microscopy. Targets for massive storage and high-end cameras.

Industrial Bio-Technology

Bio-fuels and green chemicals. Targets for industrial kilns and feedstock logistics.

Robotic Lab Automation

Liquid handling mfgs. Targets for motor hardware and firmware dev data.

Real-World Evidence (RWE)

Patient data analytics SaaS. Targets for EMR data feeds and secure cloud.

Bio-Sector Media & PR

Specialized storytelling. Targets for influencer databases and event data.

Anatomy of a High-Value BioTech Lead

In BioTech, the "Pipeline Stage" determines the enterprise value. A company with a public Phase II Trial and proprietary IND (Investigational New Drug) status is a top-tier account.

We extract these "Scientific Signals" to help you find the builders.

Tech Fingerprints

  • LIMS: Detection of Benchling, Dotmatics, or LabWare signatures.
  • Modeling: Usage of Schrodinger, BioVia, or custom Python pipelines.
  • Platform: Presence of `/research` or links to clinicaltrials.gov.

Clinical Signals

  • FDA Phase: Explicit match against ClinicalTrials.gov for "Active" recruiting.
  • Patents: Match against USPTO for biological synthesis or novel proteins.
  • Hiring: Roles for "Principal Scientist," "Clinical Ops Manager," or "RA Specialist."

Outreach Strategy: The "Regulatory" Play

If you sell quality management software, filter for startups with Phase I data but no "QMS" or "eTMF" mention.
Pitch: "Avoid clinical delays by automating your GLP/GCP documentation directly from your lab bench..."

Verification: The "Foundry" Check

We distinguish between companies that do science and companies that do business.

  • Registry Match: Is the firm listed in the BIO or PhRMA organization rosters?
  • Facility: Does the address match a site with high-bay R&D or BSL-2/3 lab space?
  • News: Are they announcing recent funding rounds or partnership milestones?

This ensures you pitch to actual manufacturers, not just theoretical research groups.

Code the Future of Biology

Get the data that powers the global BioTech ecosystem.